← All trials
NCT05540028
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 28, 2022
- Primary completion
- Sep 20, 2024
- Completion date
- Feb 7, 2025
- First posted
- Sep 14, 2022
- Last posted
- Nov 9, 2022
- Enrollment
- 520
- Arms / groups
- 6 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Inventprise Inc.Lead sponsor
- University of British ColumbiaCollaborator
- Canadian Center for VaccinologyCollaborator
- Canadian Center for VaccinologyOverall official - principal investigator
- PATHCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.